Abstract-Contractile
It has been observed that prostaglandin E1 (PGE1) and E2 (PGE2) suppressed cardiac acceleration and release of noradrenaline (NA) in response to sympathetic nerve stimulation in isolated rabbit hearts (1-5). Similar findings have also been observed in the spleen (3, 6), vas deferens (3, 7, 8) and blood vessels (9) in various species. PGE1 and PGE2 are also released by the nerve stimulation (10, 11). Therefore, it has been postulated that the released PGE series act on the prejunctional site and control the subsequent release of NA (5). Recently, the existence of a similar negative feedback mechanism was suggested in parasympathetic nerves innervating rabbit and mouse hearts (12-14).
On the other hand, broncho-constriction in situ in response to parasympathetic nerves was prevented by PGE1 in rabbits and guinea-pigs (15). PGE1 and PGE2 prevented the contractile response of the isolated canine tracheal muscle to transmural nerve stimulation (16).
The present study was undertaken to investigate the effects of other prostaglandins (PGs) on the contractile responses to transmural nerve stimulation and to exogenously administered ACh in isolated canine tracheal muscle.
MATERIALS AND METHODS
Mongrel dogs of either sex, weighing 8 to 15 kg were anesthetized with pentobarbital sodium (35 mg/kg, i.v.) and exsanguinated from the bilateral common carotid arteries.
The cervical trachea was excised.
Recording of the muscle contraction was made using the same method previously described (16 (log g/ml). x x ; Vehicle (equi-volume of the solvent with 10_5 g/ml of PGs). '_;
O; PGA1 (10-1 gjml) treated group. 0; PGA2 (10-s g/ ml) treated group.
A -A; PGB2 (10-s g/rnl) treated group. 0 ~; PGF2a (10-5 g/ml) treated group.
Each point shows the mean---standard error (Number of animals -4).
RESULTS

I. Effects of PGs on the contractile response to exogenously administered ACh
PGs rarely produced any effect on the tone of the isolated tracheal muscle. However, when the muscular tone was elevated by 10-6 g/ml of ACh, more than 10-6 g/ml of PGE1 produced a relaxation. The pretreatment (10 min before) of 10-5 g/ml of PGA1, PGA2, PGB2 or PGF2a slightly depressed the contractile response to exogenously administered ACh (cumulative method). However, the inhibition was statistically not significant from the inhibition induced by the vehicle (equi-volume of the solvent with 10-s g/ml of PGs) (Fig. 1 ).
The pretreatment with 10-6 g/ml of PGE1 or PGE2 had almost no effect on the contractile response to ACh, thus confirming the previous finding (16).
FIG. 2. Effects of PGAI and PGA2 on the contractile response of isolated tracheal
muscle to field stimulation in dogs. Ordinate; % of control (the height of con traction induced by field stimulation before drug administration was 100). Abscissa; time course after drug administration (min). x x ; Vehicle (equi-volume of the solvent with 10-5 g/ml of PGs) treated group. 0-(.--'; PGAI (l0-1 g/ml) treated group. •--®; PGAI (10-6 g/ ml) treated group. 0 A; PGA2 (10_5 g/ml) treated group. 0; PGA2 (10-6 g/ml) treated group. Each point shows the mean -'-standard error (Number of animals=4). *P<0.05; significantly differed from the value of vehicle treated group. and 47.2±13.8% (the mean *S. E., N=4), respectively, 15 min after the administration of 10-6 and 10-1 g/ml of PGA1 (Fig. 2) . These values were statistically significant from the value obtained by the vehicle (P<0.05).
FIG. 4. Effects of PGE1, PGE2 and PGF2a on the contractile response of isolated
tracheal muscle to field stimulation in dogs. Ordinate; % of the control (height of contraction induced by field stimulation before drug administration was 100). Abscissa; time course after drug administration (min). x x ; Vehicle (equi volume of the solvent with 10-6 g/ml of PGs) treated group. ;< <; PGF2a
(10-7 g,/ml) treated group. 0-9; PGF2a (10-1g/ml) treated group. ~< A; PGE1 (10-6 g/ml) treated group. 0/ <; PGEz (10-6 g/ml) treated group. Each point shows the mean+standard error (Number of animals-4). *P<0.05, **P<0 .02; significantly differed from the value of the vehicle treated group.
The administration of 10_; to 10-6 g/ml of PGA2 or PGB2 also depressed the contractile response, but the depressive effects of these drugs were weaker than that of PGA1 (Figs. 2 and 3). As previously reported (16), PGE1 and PGE2 in the dose of 10-6 g/ml strongly depressed the contractile response. The depressive effect of PGE1 was more potent than that of PGE2 (Fig. 4) . PGF2a had a slight depressive effect on the contractile response (Fig. 4) . The order of the potencies of the depressive effect was as follows; PGE1<PGE2< PGA1<PGA2 -PG B2= PGF9a. The depressive effects of PGs on the contractile response to the transmural nerve stimulation disappeared after washout of PG.
III. Effect of indomethacin on the contractile response to exogenously administered ACh and transmural nerve stimulation
Indomethacin in a dose of 10-6 g/ml slightly reduced the muscular tone of some of the strips. Pretreatment (30 min before) with indomethacin in a dose of 10-6 g/ml, potentiated the contractile response to exogenously administered ACh (Fig. 5) and to the transmural nerve stimulation (Fig. 6 ). PGE1 in a dose of 10-6 g/ml remarkably depressed the aug mented contractile response to the transmural nerve stimulation in the presence of 10-6 g/ml of indomethacin.
However, the increase of the dose of indomethacin to 10-1 g/ml at tenuated its enhancing effect on the contractile response to exogenously administered ACh (not shown in figure) and to transmural nerve stimulation (Fig. 6) . Ordinate; % of the control (the height of contraction induced by 10-1 g/ml of ACh was 100). Abscissa; doses of ACh (log g/ml). < C ; Control (untreated) group.
®-O; Indomethacin (10-6 g/ml) treated group. Each point shows the mean±standard error (Number of animals-4).
`P<0.05; the difference be tween the values obtained in the same dose of ACIi was statistically significant.
FiG. 6. Effect of pretreatment with indome
thacin on the contractile response of isolated tracheal muscle to field stimula tion. Ordinate; % of the control (the height of contraction induced by field stimulation before drug administration was 100). Abscissa; time course after drug administration (min). <---0; In domethacin (10-6 g/ml) treated group.
•-®;
Indomethacin (10-1 g/ml) treated group. Each point shows the mean± standard error (Number of animals=4). 0P<0 .05; significantly differed from the control.
DISCUSSION
Existence of a feedback control mechanism in sympathetic nerve transmission through endogenous PGE series has been suggested (10). A similar mechanism has also been suggested in parasympathetic nerves (12). Our previous study showed that contractile response of the isolated canine tracheal muscle to the transmural nerve stimulation was predominantly mediated through cholinergic nerves (16). PGE1 and PGE2 prevented contractile response to the transmural nerve stimulation, while the response to exogenously administered ACh was almost unaffected or was only slightly depressed. Therefore, the aforementioned feedback control mechanism may work in parasympathetic nerves in nervating canine tracheal muscle. Comparison with other PGs, PGE series, particularly PGE1 had the most potent inhibitory action on sympathetic nerves (2) and parasympathetic nerves (12, 14, 17) in the heart. The present study also demonstrated that the PGE series was the most potent inhibitory substance among PGs. Therefore, it seems that, if the feedback mechanism does exist in the autonomic nerves, PGE series is a specific substance involved in the mechanism. The resting tone of the tracheal muscle used in the present study was low, and PGE1 produced a relaxation only when the muscular tone was elevated by ACh. The finding is consistent with the results that PGs caused relaxation, when the muscle had an isometric tone (18) . Tiirker and Khairallah (19) also observed that in a dose of over 0.5 x 10-s g/ml PGE1 produced a relaxation in the muscle contracted by 10-8 g/ml of ACh. In contrast to PGE1i PGF2a produced a contraction in human bronchial muscle (20) . However, PGF2a did not contract canine tracheal muscle.
Indomethacin inhibits the biosynthesis of PGs (21) . In the presence of indomethacin, the contractile response to the transmural nerve stimulation was considerably potentiated, and such may be due to a partial removal of the negative feedback control through the PGE series (22) . However, at least in part, indomethacin may act on postsynaptic sites since exogenously administered ACh was also potentiated by the drug. The potentiating effect of indomethacin on both nerve-mediated and ACh-induced contraction weakened as the administered dose was increased. Farmer et al. (23) 
